The Federal Government's recent announcement of a free RSV vaccine for pregnant women under the National Immunisation Program (NIP) has been welcomed by the Royal Australian College of General Practitioners (RACGP). This $174.5 million initiative, set to commence from 3 February, aims to protect newborns from respiratory syncytial virus (RSV), a leading cause of hospitalisation in infants across Australia.
Each year, approximately 12,000 infants are hospitalised due to severe RSV infections, making it the most common reason for infant hospital admissions nationwide. The introduction of a free vaccine provides a critical opportunity for GPs to play a pivotal role in preventing these infections and ensuring better health outcomes for newborns.
RACGP President, Dr Michael Wright, has strongly advocated for the uptake of this vaccine, highlighting its potential to significantly reduce severe RSV cases and financial burdens on families. GPs are encouraged to discuss the importance of RSV immunisation with expectant mothers and integrate it into their routine antenatal care.
Dr Wright emphasised that the vaccine offers a vital layer of protection, potentially preventing serious illness and hospitalisation. Given that nearly all infants will encounter RSV within their first year, proactive immunisation efforts will be crucial in reducing the overall burden of the virus.
GPs should start planning now by:
The RACGP will be working closely with the Government to facilitate a seamless rollout and provide necessary support to general practices. By prioritising RSV vaccination, GPs can contribute significantly to improving infant health outcomes across Australia.
For further details on the program and implementation guidelines, stay updated with RACGP announcements and resources.
RACGP Media Release: Free RSV Vaccine for Newborns: What GPs Need to Know
Tags: